Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) Guidelines on the Use of Granulocyte Colony-Stimulating Factor (G-CSF) for Lymphoma Care

Author： Pettengell Ruth  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.29, Iss.8, 2009-08, pp. : 491-513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Granulocyte Colony-Stimulating Factor (G-CSF) for Cardio- and Cerebrovascular Regenerative Applications

By  

Current Medicinal Chemistry, Vol. 15, Iss. 10, 2008-04 ,pp. : 968-977

Bentham Science Publishers

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor (G-CSF) appears to increase the risk of therapy-related myeloid leukaemia

By  

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Granulocyte Colony-Stimulating Factor (G-CSF) in the Mechanism of Human Ovulation and its Clinical Usefulness

By  

Current Medicinal Chemistry, Vol. 15, Iss. 6, 2008-03 ,pp. : 604-613

Bentham Science Publishers

Access to resources Recommend Favorite

Combining fludarabine, cytarabine [Ara-C], idarubicin plus granulocyte colony-stimulating factor (G-CSF) is effective for refractory acute leukaemias

By  

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Granulocyte colony-stimulating factor (G-CSF) does not appear to have any additional benefit in patients with acute myeloid leukaemia (AML) receiving chemotherapy

By  

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite